This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Pia Kvistborg, Ph.D. group

Kvistborg, Pia

Pia Kvistborg, Ph.D.

Junior Group Leader

Personal details

Experience

I have been working at the NKI since August 2010 and my main focus is immune monitoring of cancer patients treated with immune therapeutic interventions.

The main goal of this line of work is threefold:

1. Addressing what type of T cell specificities are relevant for clinical outcome to. Such knowledge will help trying to steer immune interventions and hopefully improve them.

2. Dissection of how immune interventions affects the cytotoxic T cell repertoire in cancer patients to create knowledge about the mechanism of action.

3. Assessment of immune competence of patients. No definite readout of immune competence is established yet but if we can achieve this it might help predict if patients can benefit from immune interventions.

We are mainly working with polychromatic flow cytometry and in particular the peptide MHC combinatorial coding approach to assess these questions but also functional status of T cells.

Share this page